Envelope surface glycoprotein gp120
|
env
|
Levels of IL-12 in LPS-treated myeloid dendritic cells are modulated in the presence of HIV-1 gp120 |
PubMed
|
|
env
|
HIV-1 gp120 inhibits early and late production of interleukin (IL)-12 by peripheral blood mononuclear cells (PBMC) |
PubMed
|
|
env
|
Secretion of IL-12 is found in macrophages primed with gamma interferon (IFN-gamma) and subsequently treated with gp120 |
PubMed
|
|
env
|
Apoptosis of CD4+ lymphocytes induced by HIV-1 gp120 cross-linking to CD4 is inhibited by IL-12 |
PubMed
|
|
env
|
HIV-gp120 induces a significant IL-10 synthesis, which in turn inhibits IL-12 subunits mRNA accumulation and protein secretion after Staphylococcus aureus strain cowan I (SAC)-activation |
PubMed
|
Envelope surface glycoprotein gp160, precursor
|
env
|
IL-7 and IL-12 significantly augment proliferative responses to HIV-1 gp160 |
PubMed
|
|
env
|
Chimeric HIV-1 gp140 - CD40L trimers can target and activate dendritic cells to release IL-6, IL-10 and IL-12 |
PubMed
|
Nef
|
nef
|
IL-12 and GM-CSF increase the magnitude of the specific immune response with higher breadth by targeting HIV-1 Nef peptides (amino acids 9-23, 11-26, 140-155, 179-193, and 181-195) |
PubMed
|
|
nef
|
IL-1beta, IL-12, and IL-15 are factors involved in the upregulation of IFN-gamma expression in coculture between Nef-pulsed iDCs and NK cells |
PubMed
|
|
nef
|
HIV-1 Nef upregulates IL-12 release in immature human and macaque dendritic cells |
PubMed
|
Tat
|
tat
|
HIV-1 Tat upregulates IL-12 expression in Jurkat T-cells, Raji B-cells, monocyte-derived dendritic cells, and primary human Muller glia |
PubMed
|
|
tat
|
Wild-type Tat but not Cys-22 and oxidized Tat induces CD1A-expressing monocyte-derived dendritic cells (MDDC) maturation and increases the production of cytokines TNF-alpha, IL-12, MIP-1alpha, and MIP-1beta |
PubMed
|
|
tat
|
HIV-1 Tat downregulates IL-12 production by human dendritic cells by blocking extracellular calcium influx |
PubMed
|
|
tat
|
HIV-1 Tat downregulates IL-12 production by human peripheral blood mononuclear cells (PBMCs) |
PubMed
|
Vpr
|
vpr
|
HIV-1 Vpr impairs NK cell function through cytokine dysregulation, including diminshed expression of CD107a, reduced production of IFN-gamma, differential regulation of IL-12 and TGF-beta, and activation of the Smad3 signalling pathway |
PubMed
|
|
vpr
|
The C-terminal domain or the R90 residue of HIV-1 Vpr are important for Vpr-mediated IL-12 degradation via ubiquitin-dependent pathway |
PubMed
|
|
vpr
|
HIV-1 Vpr downregulates the production of interleukin 12 (IL-12) in dendritic cells |
PubMed
|
|
vpr
|
HIV-1 Vpr suppresses expression and secretion of IL-12 subunit p35 and IL-12 holo-protein, but not IL-12 subunit p40 |
PubMed
|
matrix
|
gag
|
HIV-1 Matrix upregulates levels of IL-2, IL-12 and IL-15 in natural killer cells and induces natural killer cell proliferation |
PubMed
|
reverse transcriptase
|
gag-pol
|
The addition of anti-IFN-gamma antibodies block the IL-12-induced downregulation of HIV-1 RT activity in HIV-1-infected macrophages |
PubMed
|